drugset
drugset / Trial / NCT02571296

The Value of Oral Micronized Progesterone in the Prevention of Spontaneous Preterm Birth

NCT02571296 ↗

Phase 4 Unknown 212 enrolled Ghamra Military Hospital Ain Shams Maternity Hospital · collab
RandomizedParallel-groupTriple-blindPrevention

Summary

This is a randomized, double-blind, placebo-controlled study.

Timeline

Start
2015-07
Primary completion
2016-04
Completion
2016-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Progesterone Other / unclassified 100 mg Oral

Indications

No indication recorded.